15:51 Dec 27
Concord Biotech Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Biotechnology
Concord Biotech Ltd.
Industry Biotechnology
15:51 Dec 27
Quality
75/100
High Financial Strength
Valuation
12/100
Expensive Valuation
Technical
62/100
Technically Moderately Bullish
Strength
12
Weakness
1
Opportunity
1
Threats
1
22.65K
Market Cap (Cr)
69.08
PE Ratio
14.24
Price to Book Ratio
57.27
RSI
30.29 %
Net Profit Margin
Download Our App On:
